For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Quick Links
Medicine Update issuesMedicine Update issues
Medicine Update lets you know about new medicines and new PBS listings. Each issue provides an independent assessment of current information and research about a different medicine.
Find out more about Medicine Update.
| Title | Date | Why read this |
|---|---|---|
| Asenapine (Saphris) for bipolar I disorder | 2011-12-01 00:00:00 | Asenapine (Saphris) is an antipsychotic medicine used to treat the ‘high’ or manic episodes associated bipolar I disorder. This Medicine Update includes unbiased information on what asenapine is, how it works and who can take it. |
| Asenapine (Saphris) for schizophrenia | 2011-12-01 00:00:00 | Asenapine (Saphris) is an antipsychotic medicine used to reduce psychotic symptoms in schizophrenia. This Medicine Update includes unbiased information on what asenapine is, how it works and who can take it. |
| Indacaterol (Onbrez) for chronic obstructive pulmonary disease (COPD) | 2011-12-01 00:00:00 | Indacaterol (Onbrez) is an inhaler medicine used to treat the symptoms of chronic obstructive pulmonary disease (COPD). It is inhaled once a day using a device called a Breezhaler to help relax the airways in the lungs. This Medicine Update includes information on what indacaterol is, how it works and who can use it. |
| Dabigatran (Pradaxa) for preventing stroke in people with atrial fibrillation | 2011-08-05 00:00:00 | This Medicine Update is about using dabigatran to prevent stroke in people with a condition called atrial fibrillation. Dabigatran can also be used after hip or knee replacement surgery (see the April 2010 Medicine Update issue). |
| Melatonin prolonged-release tablets (Circadin) for insomnia | 2011-08-05 00:00:00 | Melatonin prolonged-release tablets (Circadin) can be used by people over 55 years of age to treat sleeping problems (insomnia) not caused by other physical or psychological conditions. |
| Varenicline (Champix) for quitting smoking | 2011-08-02 00:00:00 | This Medicine Update tells you about varenicline (Champix), a medicine to help you quit smoking. Find out what varenicline does, its side effects, and how it compares with other medicines for quitting. Find out about ways to quit without medicines too. |
| Saxagliptin (Onglyza) for type 2 diabetes | 2011-07-01 00:00:00 | This Medicine Update tells you about saxagliptin (Onglyza), a new medicine to help control blood glucose in type 2 diabetes. Find out how it fits with other diabetes medicines, its side effects, and other ways to help manage type 2 diabetes. |
| Denosumab (Prolia) for postmenopausal osteoporosis. | 2010-12-16 00:00:00 | Information on denosumab, a medicine used for treatment of postmenopausal osteoporosis. |
| Exenatide (Byetta) for type 2 diabetes | 2010-12-16 00:00:00 | This issue provides information on exenatide (Byetta) for the treatment of type 2 diabetes. |
| Panadol Extra (paracetamol and caffeine) for pain | 2010-12-16 00:00:00 | This Medicine Update is for people who are taking, or thinking about taking, Panadol Extra. |
| Sitagliptin (Januvia) for type 2 diabetes | 2010-08-20 00:00:00 | This Medicine Update is for people who are taking, or thinking about taking, sitagliptin for type 2 diabetes. |
| Vildagliptin (Galvus) for type 2 diabetes | 2010-08-20 00:00:00 | This Medicine Update is for people who are taking, or thinking about taking, vildagliptin for type 2 diabetes. |
| Pramipexole (Sifrol and Sifrol ER) for Parkinson’s disease | 2010-08-02 00:00:00 | A new, long-acting form of pramipexole (Sifrol ER) is available for Parkinson’s disease. This revised Medicine Update describes the potential benefits, side effects and issues to be aware of with pramipexole (Sifrol) or the long-acting form (Sifrol ER). |
| Dabigatran (Pradaxa) for preventing blood clots after hip or knee replacement surgery | 2010-04-12 00:00:00 | Dabigatran can be used to prevent blood clots forming after hip or knee replacement surgery. It works by thinning the blood. |
| Rivaroxaban (Xarelto) for preventing blood clots after hip or knee replacement surgery | 2010-04-12 00:00:00 | Rivaroxaban is a new medicine to prevent blood clots forming after hip or knee replacement surgery. It works by thinning the blood. |
| Zoledronic acid (Aclasta) for osteoporosis | 2009-04-01 00:00:00 | Information for consumers about zoledronic acid (Aclasta), a new treatment for osteoporosis. This treatment is used only once a year, and is given through a drip into a vein. |
| Tramadol for pain | 2008-12-01 00:00:00 | Information for consumers about tramadol, a painkiller prescribed by your doctor. |
| Duloxetine (Cymbalta) for major depression | 2008-08-01 00:00:00 | Information for consumers about duloxetine (Cymbalta), a new antidepressant for major depression. |
| Strontium ranelate (Protos) for osteoporosis in postmenopausal women | 2008-04-01 00:00:00 | Information for consumers about strontium ranelate (Protos) for osteoporosis in postmenopausal women. |
| Alendronate (Fosamax) for osteoporosis - preventing fractures in people with very fragile bones (low bone mineral density) | 2008-01-01 00:00:00 | Information for consumers about the drug Alendronate for preventing fractures in people with very fragile bones (low bone mineral density) and osteoporosis. |
| Fluticasone with salmeterol (Seretide) for chronic obstructive pulmonary disease | 2008-01-01 00:00:00 | Information for consumers about the drug Seretide, for chronic obstructive pulmonary disease. |
| Lumiracoxib (Prexige) for osteoarthritis | 2007-04-01 00:00:00 | Since this issue of Medicine Update was published, lumiracoxib (Prexige) has been withdrawn by the Therapeutic Goods Administration. |
Date published: 2009-07-31 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
